Molina Healthcare, Inc. (NYSE: MOH) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
191.36
-3.41-1.75%
TA
Loading chart...
Snapshot
| Index | - | P/E | - | EPS (ttm) | 0.19 | Insider Own | 1.65% | Shs Outstand | 52.20M | Perf Week | -4.48% |
| Market Cap | 9.99B | Forward P/E | 19.61 | EPS next Y | 9.76 | Insider Trans | -2.10% | Shs Float | 48.58M | Perf Month | -15.96% |
| Enterprise Value | 5.03B | PEG | 21.35 | EPS next Q | 0.83 | Inst Own | - | Short Float | 6.86% | Perf Quarter | -2.13% |
| Income | -7.00M | P/S | 0.22 | EPS this Y | 2654.22% | Inst Trans | - | Short Ratio | 2.93 | Perf Half Y | 5.62% |
| Sales | 44.52B | P/B | 2.39 | EPS next Y | 86.50% | ROA | -0.04% | Short Interest | 3.33M | Perf YTD | 10.27% |
| Book/sh | 79.90 | P/C | 1.12 | EPS next 5Y | 47.18% | ROE | -0.17% | 52W High | 244.89 -21.86% | Perf Year | 23.35% |
| Cash/sh | 170.79 | P/FCF | 37.68 | EPS past 3/5Y | -12.99% -4.52% | ROIC | 3.52% | 52W Low | 121.06 58.07% | Perf 3Y | -36.52% |
| Dividend Est. | - | EV/EBITDA | 13.55 | Sales past 3/5Y | 12.42% 18.52% | Gross Margin | 34.56% | Volatility | 2.60% 4.50% | Perf 5Y | -26.49% |
| Dividend TTM | - | EV/Sales | 0.11 | EPS Y/Y TTM | -99.07% | Oper. Margin | 0.66% | ATR (14) | 9.25 | Perf 10Y | 262.29% |
| Dividend Ex-Date | - | Quick Ratio | 1.68 | Sales Y/Y TTM | 9.53% | Profit Margin | -0.02% | RSI (14) | 32.91 | Recom | 2.72 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.68 | EPS Q/Q | -72.45% | SMA20 | -11.31% | Beta | 0.71 | Target Price | 194.46 |
| Payout | 0.00% | Debt/Eq | 0.97 | Sales Q/Q | -4.84% | SMA50 | -7.51% | Rel Volume | 0.44 | Prev Close | 194.77 |
| Employees | 19,000 | LT Debt/Eq | 0.97 | Earnings | Oct 28 | SMA200 | 10.83% | Avg Volume | 1.19M | Price | 191.36 |
| IPO Date | Jul 02, 2003 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 8.59% 0.39% | Net Debt/EBITDA | -2.78 | Volume | 529,756 | Change | -1.75% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-28-26 | Reiterated | Wells Fargo | Equal Weight | $235 → $220 |
| Jul-24-26 | Reiterated | RBC Capital | Sector Perform | $248 → $218 |
| Jul-24-26 | Reiterated | Barclays | Underweight | $184 → $180 |
| Jul-14-26 | Reiterated | Jefferies | Hold | $160 → $230 |
| Jul-14-26 | Reiterated | Truist Securities | Hold | $205 → $250 |
| Jul-13-26 | Reiterated | Bernstein | Outperform | $224 → $286 |
| Jul-13-26 | Reiterated | Wells Fargo | Equal Weight | $159 → $235 |
| Jul-09-26 | Reiterated | RBC Capital | Sector Perform | $216 → $248 |
| Jun-23-26 | Initiated | RBC Capital | Sector Perform | $216 |
| Jun-08-26 | Reiterated | Mizuho Securities | Outperform | $200 → $215 |
Latest News
Jul-29-26
Jul-25-26
Jul-24-26
Jul-23-26
06:43PM
Jul-22-26
06:56PM
04:15PM
Molina Healthcare Reports Second Quarter 2026 Financial Resultsbusinesswire.com
Jul-21-26
Jul-21-2610:16AM
Jul-19-26
Jul-16-26
Jul-16-2605:56PM
Jul-09-26
Jul-03-26
Jul-01-26
Company
Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 44,522 | 45,426 | 40,650 | 34,072 | 31,974 | 27,771 | 19,423 | 16,829 | 18,890 | |
| Cost of Goods Sold Incl. D&A | 29,135 | 39,488 | 35,914 | 29,738 | 28,048 | 24,491 | 16,746 | 14,394 | 16,266 | |
| Gross Profit | 15,387 | 5,938 | 4,736 | 4,334 | 3,926 | 3,280 | 2,677 | 2,435 | 2,624 | |
| Selling, General and Administrative Excl. Other | 3,027 | 3,009 | 2,743 | 2,462 | 2,311 | 2,068 | 1,480 | 1,296 | 1,333 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 12,064 | 2,148 | 286 | 299 | 234 | 192 | 119 | 89 | 15,680 | |
| Operating Income | 296 | 781 | 1,707 | 1,573 | 1,381 | 1,020 | 1,078 | 1,044 | 1,131 | |
| Interest Expense | 209 | 192 | 118 | 109 | 110 | 120 | 102 | 87 | 115 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -93 | 0 | 0 | 0 | -208 | -25 | -15 | 15 | -17 | |
| Net Income Before Taxes | -6 | 589 | 1,589 | 1,464 | 1,063 | 875 | 961 | 972 | 999 | |
| Income Taxes | 1 | 117 | 410 | 373 | 271 | 216 | 288 | 235 | 292 | |
| Consolidated Net Income | -7 | 472 | 1,179 | 1,091 | 792 | 659 | 673 | 737 | 707 | |
| Net Income From Continuing Operations | -7 | 472 | 1,179 | 1,091 | 792 | 659 | 673 | 737 | 707 | |
| Net Income | -7 | 472 | 1,179 | 1,091 | 792 | 659 | 673 | 737 | 707 | |
| EPS (Recurring) | 0.16 | 8.93 | 20.52 | 18.71 | 13.70 | 11.40 | 11.41 | 11.85 | 10.61 | |
| EPS (Basic, Before Extraordinaries) | 0.16 | 8.93 | 20.52 | 18.71 | 13.70 | 11.40 | 11.41 | 11.85 | 10.61 | |
| EPS (Diluted) | 0.19 | 8.92 | 20.42 | 18.78 | 13.54 | 11.25 | 11.24 | 11.48 | 10.55 | |
| EBITDA | 371 | 976 | 1,893 | 1,744 | 1,349 | 1,126 | 1,151 | 1,148 | 1,241 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 1,007.16 | 19.46 | 14.25 | 19.24 | 24.39 | 28.27 | 18.92 | 11.82 | 11.02 | |
| Price To Sales Ratio | 0.22 | 0.19 | 0.41 | 0.62 | 0.60 | 0.66 | 0.65 | 0.50 | 0.41 | |
| Gross Margin | 34.56 | 13.07 | 11.65 | 12.72 | 12.28 | 11.81 | 13.78 | 14.47 | 13.89 | |
| Operating Margin | 0.66 | 1.72 | 4.20 | 4.62 | 4.32 | 3.67 | 5.55 | 6.20 | 5.99 | |
| Net Margin | -0.02 | 1.04 | 2.90 | 3.20 | 2.48 | 2.37 | 3.46 | 4.38 | 3.74 | |
| Shares Outstanding | 51 | 51 | 57 | 58 | 58 | 58 | 59 | 62 | 67 | |
| Market Capitalization | 9,759 | 8,851 | 16,590 | 20,956 | 19,153 | 18,449 | 12,548 | 8,413 | 7,787 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| HEBERT MAURICE | Chief Accounting Officer | May 14 '26 | Sale | 191.55 | 600 | 114,930 | 12,815 | May 15 |
| Barlow Jeff D. | Chief Legal Officer | May 11 '26 | Sale | 186.12 | 17,811 | 3,314,983 | 67,175 | May 13 |
| ROMNEY RONNA | Director | Mar 12 '26 | Sale | 146.92 | 506 | 74,342 | 17,227 | Mar 13 |
| ZORETIC RICHARD C | Director | Feb 11 '26 | Buy | 125.16 | 800 | 100,128 | 8,747 | Feb 12 |
| Schapiro Richard M | Director | Nov 24 '25 | Sale | 143.02 | 357 | 51,058 | 11,352 | Nov 24 |
| ROMNEY RONNA | Director | Aug 06 '25 | Sale | 153.74 | 700 | 107,618 | 17,131 | Aug 08 |
| WOYS JAMES | Chief Operating Officer | Aug 04 '25 | Buy | 155.94 | 10,000 | 1,559,365 | 74,331 | Aug 06 |
| WOLF DALE B | Director | May 21 '25 | Sale | 322.89 | 1,500 | 484,328 | 14,209 | May 22 |
| ORLANDO STEVEN J | Director | May 05 '25 | Sale | 318.58 | 1,000 | 318,580 | 16,543 | May 05 |
| Zubretsky Joseph M | President & CEO | Apr 30 '25 | Sale | 320.06 | 87,500 | 28,005,170 | 257,715 | May 02 |
| Schapiro Richard M | Director | Apr 29 '25 | Sale | 320.50 | 669 | 214,415 | 11,244 | May 01 |
| ORLANDO STEVEN J | Director | Mar 03 '25 | Sale | 301.33 | 1,000 | 301,330 | 17,375 | Mar 04 |
| Schapiro Richard M | Director | Nov 18 '24 | Sale | 292.72 | 136 | 39,810 | 11,556 | Nov 19 |
| HEBERT MAURICE | Chief Accounting Officer | Aug 15 '24 | Sale | 346.52 | 393 | 136,182 | 9,473 | Aug 16 |
| ORLANDO STEVEN J | Director | Jul 30 '24 | Sale | 339.21 | 1,000 | 339,210 | 18,025 | Jul 30 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.